US firm discovers primitive adult stem cells in blood that may lead to therapies:
This article was originally published in Clinica
Executive Summary
Adult stem cell specialists Moraga Biotechnology has discovered Blastomere-Like Stem Cells (BLSCs) - now a proprietary product - in the peripheral blood of mammals. The firm claims that the cells are able to differentiate into most cells in the body, and may eventually be used to treat conditions such as heart attack and stroke. In addition, Moraga has developed a new method for isolating and purifying large numbers of these cells without ex vivo expansion. In the future, the Los Angeles, California-based company hopes to use the technology to create a stem cell bank simply using blood samples.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.